|
|
Last Modified: 10/24/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
0 to 18
|
|
|
|
NCI
|
|
|
|
CCG-3891
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
no greater than 60
|
|
|
|
NCI
|
|
|
|
NU-93B1 NCI-T93-0058D, T93-0058
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
65 and under
|
|
|
|
Other
|
|
|
|
PCI-9404 NCI-V94-0494
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 11/1/1994 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
under 65
|
|
|
|
|
|
|
|
MRC-LEUK-MYEL-VII EU-94030, NCT00002599
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
56 and over
|
|
|
|
NCI
|
|
|
|
SWOG-9333
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 70
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CP-0060-002 NCI-V95-0712
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
MSKCC-96015A1 NCI-V96-0881, NCT00002766
|
|
|
|
|
|
|
|
Last Modified: 10/22/2007  First Published: 6/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Under 50
|
|
|
|
NCI
|
|
|
|
COG-D9602 CCG-D9602, POG-D9602, IRS-D9602, D9602, NCT00002995
|
|
|
|
|
|
|
|
Last Modified: 8/3/2007  First Published: 12/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Under 21
|
|
|
|
NCI
|
|
|
|
COG-A3961 CCG-A3961, POG-A3961, NCT00003093, A3961
|
|
|
|
|
|
|
|
Last Modified: 8/3/2007  First Published: 12/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Under 21
|
|
|
|
NCI
|
|
|
|
COG-P9641 POG-P9641, CCG-P9641, NCT00003119, P9641
|
|
|
|